탁상형 폐활량계 시장 - 예측(2024-2029년)

The tabletop spirometer market is projected to grow at a CAGR of 3.03% to reach a value of US$1,142.252 million by 2029, from US$927.169 million in 2022.

Air pollution levels are rising globally, primarily due to the increasing emissions from vehicles and the rising number of industries worldwide. This increase in the pollution level has resulted in a rise in the prevalence of Chronic Obstructive Pulmonary Disease (COPD), which is one of the leading causes of death, according to the World Health Organization (WHO).

This spike in the number of cases of respiratory diseases has spiked the demand for tabletop spirometers, which is a major driving factor in the market's growth. The use of such advanced devices results in the early detection of harmful diseases in the early stages so that serious damage to the body is mitigated effectively and efficiently.

Rising investments to boost the healthcare infrastructure across both developed and developing economies are also contributing to the market growth of tabletop spirometers. The growing global geriatric population is another major driver of the tabletop spirometer market. This is because aged people are more prone to diseases due to their weakened immune systems and decreased efficacy of vital organs.

Market Drivers:

• Advancement in technology

Key players in the tabletop market are investing in and offering top-of-the-line, enhanced products with good features to expand their global market share. This propels the market growth of tabletop spirometers during the forecast period.

For example, SEIBELMED, a manufacturer and marketer of medical products, offers a product, "DATOSPIR TOUCH", which is a touchscreen spirometer device with a built-in printer, integrated temperature sensor, rechargeable battery and operates on three modes- primary health, occupational care, and diagnostics. It can perform bronchodilation, FVC (Forced Vital Capacity), VC (Vital Capacity), and MVV (Maximum Voluntary Ventilation) tests. Moreover, it also displays adult and pediatric incentive graphs that support USB and Bluetooth connectivity and are suitable for telemedicine.

• Growing cases of respiratory diseases

The incidence of respiratory ailments is steadily increasing worldwide, driven by factors such as air pollution, tobacco use, and the aging demographic. Chronic respiratory diseases like asthma, COPD, and cystic fibrosis are becoming more prevalent as a result.

In the United States, for instance, the percentage of adults diagnosed with COPD, emphysema, or chronic bronchitis stood at 4.6% in 2022. Consequently, there is a growing need for spirometry, a diagnostic tool essential for assessing and tracking these conditions' progression.

• Growing awareness about respiratory health

Increasing awareness regarding respiratory health is prompting individuals to take proactive measures in monitoring their lung function. This heightened awareness is driving the demand for home spirometry testing, particularly utilizing tabletop spirometers. The prevalence of ambient air pollution, prevalent in both urban and rural areas is exacerbating respiratory concerns. Fine particulate matter resulting from outdoor air pollution is linked to various health issues, including strokes, heart diseases, lung cancer, and acute and chronic respiratory ailments.

Furthermore, approximately 2.4 billion people are exposed to hazardous levels of household air pollution. This exposure occurs while utilizing polluting cooking methods such as open fires or rudimentary stoves fueled by sources like kerosene, biomass (such as wood, animal dung, and crop waste), and coal. These factors collectively underscore the critical importance of addressing respiratory health concerns and implementing measures to mitigate the adverse effects of air pollution on individuals' well-being.

• Growing awareness about respiratory health

Rising healthcare expenditures are prompting governments and private insurers to allocate more funds to healthcare initiatives. A recent OECD report highlights the renewed financial strain on health systems within the OECD due to competing priorities for public funding. According to the 2023 edition of OECD Health at a Glance, healthcare spending in OECD countries amounted to 9.2% of GDP in 2022, with an average per capita health spending nearing USD 5,000.

This increase in healthcare spending is driving the adoption of advanced diagnostic tools such as tabletop spirometers. These tools are becoming increasingly essential in healthcare settings to aid in the diagnosis and monitoring of respiratory health conditions.

Market Restraint:

• Presence of substitutes

There is a presence of substitutes in the market. The alternatives to tabletop spirometers include pulse oximeters, along with techniques like specific airway resistance (sRaw), interrupter resistance, and forced oscillation techniques. These substitutes hold a significantly better position in the market, which, in turn, is hampering the tabletop spirometer market growth.

Global table-top spirometer market segmentation

The global tabletop spirometer market is categorized based on type, end-user, and geographical regions. In terms of type, the market is segmented into pneumotachometer, fully electric spirometer, windmill-type spirometer, and other variants.

Pneumotachometers utilize sensors to precisely measure the speed of both inhaled and exhaled air, offering highly accurate airflow measurements. Fully electric spirometers employ a compact turbine mechanism to gauge airflow, boasting enhanced portability and user-friendliness compared to pneumotachometers.

Windmill-type spirometers, on the other hand, present a simpler and more economical option. They utilize a lightweight vane that rotates in response to airflow, and the rotation is translated into volume measurements.

Additionally, other types of tabletop spirometers include incentive spirometers, which utilize visual feedback to encourage patients to engage in deeper breathing exercises. Portable PC-connected spirometers offer more advanced data analysis capabilities, enhancing their utility for healthcare professionals.

By end-user, the market has been segmented as hospitals and clinics, ambulatory surgical centers, homes, and research and academic institutions.

North America is anticipated to hold a significant share of the tabletop spirometers market.

The growing aging population in countries like the U.S. and Canada, along with the booming home care sector, is fuelling the tabletop spirometers market growth. In addition, there are increasing investments in R&D for the improvement and enhancement of medical and healthcare facilities to cater to the increasing number of respiratory diseases, thereby positively impacting the tabletop spirometer market growth.

Market Developments:

• May 2023- IndieBio's Aluna received a $15M wave of support for its AI-enabled asthma monitoring platform. Aluna's FDA-cleared spirometer enables customers to breathe into the device daily to measure their response to medications and triggers, including environment, exercise, and location.
• January 2023- Koneksa, a healthcare technology company focused on developing evidence-based validated digital biomarkers, announced the initiation of a clinical study that compared the treatment effect between at-home mobile spirometry using digital biomarkers and in-clinic spirometry in patients with moderate asthma receiving long-acting beta-agonist (LABA) treatment.

Market Segmentation:

By Type

• Pneumotachometer
• Fully Electronic Spirometer
• Windmill-type Spirometer
• Others

By End-user

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Homecare
• Research and Academic Institutions

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• UK
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Taiwan
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. TABLETOP SPIROMETER MARKET BY TYPE

• 5.1. Introduction
• 5.2. Pneumotachometer
  • 5.2.1. Market opportunities and trends
  • 5.2.2. Growth prospects
  • 5.2.3. Geographic lucrativeness
• 5.3. Fully Electronic Spirometer
  • 5.3.1. Market opportunities and trends
  • 5.3.2. Growth prospects
  • 5.3.3. Geographic lucrativeness
• 5.4. Windmill-type spirometer
  • 5.4.1. Market opportunities and trends
  • 5.4.2. Growth prospects
  • 5.4.3. Geographic lucrativeness
• 5.5. Others
  • 5.5.1. Market opportunities and trends
  • 5.5.2. Growth prospects
  • 5.5.3. Geographic lucrativeness

6. TABLETOP SPIROMETER MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals and Clinics
  • 6.2.1. Market opportunities and trends
  • 6.2.2. Growth prospects
  • 6.2.3. Geographic lucrativeness
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Market opportunities and trends
  • 6.3.2. Growth prospects
  • 6.3.3. Geographic lucrativeness
• 6.4. Homecare
  • 6.4.1. Market opportunities and trends
  • 6.4.2. Growth prospects
  • 6.4.3. Geographic lucrativeness
• 6.5. Research and Academic Institutions
  • 6.5.1. Market opportunities and trends
  • 6.5.2. Growth prospects
  • 6.5.3. Geographic lucrativeness

7. TABLETOP SPIROMETER MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. By Type
  • 7.2.2. By End-user
  • 7.2.3. By Country
    • 7.2.3.1. United States
      • 7.2.3.1.1. Market Trends and Opportunities
      • 7.2.3.1.2. Growth Prospects
    • 7.2.3.2. Canada
      • 7.2.3.2.1. Market Trends and Opportunities
      • 7.2.3.2.2. Growth Prospects
    • 7.2.3.3. Mexico
      • 7.2.3.3.1. Market Trends and Opportunities
      • 7.2.3.3.2. Growth Prospects
• 7.3. South America
  • 7.3.1. By Type
  • 7.3.2. By End-user
  • 7.3.3. By Country
    • 7.3.3.1. Brazil
      • 7.3.3.1.1. Market Trends and Opportunities
      • 7.3.3.1.2. Growth Prospects
    • 7.3.3.2. Argentina
      • 7.3.3.2.1. Market Trends and Opportunities
      • 7.3.3.2.2. Growth Prospects
    • 7.3.3.3. Others
      • 7.3.3.3.1. Market Trends and Opportunities
      • 7.3.3.3.2. Growth Prospects
• 7.4. Europe
  • 7.4.1. By Type
  • 7.4.2. By End-user
  • 7.4.3. By Country
    • 7.4.3.1. Germany
      • 7.4.3.1.1. Market Trends and Opportunities
      • 7.4.3.1.2. Growth Prospects
    • 7.4.3.2. France
      • 7.4.3.2.1. Market Trends and Opportunities
      • 7.4.3.2.2. Growth Prospects
    • 7.4.3.3. UK
      • 7.4.3.3.1. Market Trends and Opportunities
      • 7.4.3.3.2. Growth Prospects
    • 7.4.3.4. Spain
      • 7.4.3.4.1. Market Trends and Opportunities
      • 7.4.3.4.2. Growth Prospects
    • 7.4.3.5. Others
      • 7.4.3.5.1. Market Trends and Opportunities
      • 7.4.3.5.2. Growth Prospects
• 7.5. Middle East and Africa
  • 7.5.1. By Type
  • 7.5.2. By End-user
  • 7.5.3. By Country
    • 7.5.3.1. Saudi Arabia
      • 7.5.3.1.1. Market Trends and Opportunities
      • 7.5.3.1.2. Growth Prospects
    • 7.5.3.2. UAE
      • 7.5.3.2.1. Market Trends and Opportunities
      • 7.5.3.2.2. Growth Prospects
    • 7.5.3.3. Israel
      • 7.5.3.3.1. Market Trends and Opportunities
      • 7.5.3.3.2. Growth Prospects
    • 7.5.3.4. Others
      • 7.5.3.4.1. Market Trends and Opportunities
      • 7.5.3.4.2. Growth Prospects
• 7.6. Asia Pacific
  • 7.6.1. By Type
  • 7.6.2. By End-user
  • 7.6.3. By Country
    • 7.6.3.1. China
      • 7.6.3.1.1. Market Trends and Opportunities
      • 7.6.3.1.2. Growth Prospects
    • 7.6.3.2. Japan
      • 7.6.3.2.1. Market Trends and Opportunities
      • 7.6.3.2.2. Growth Prospects
    • 7.6.3.3. India
      • 7.6.3.3.1. Market Trends and Opportunities
      • 7.6.3.3.2. Growth Prospects
    • 7.6.3.4. South Korea
      • 7.6.3.4.1. Market Trends and Opportunities
      • 7.6.3.4.2. Growth Prospects
    • 7.6.3.5. Indonesia
      • 7.6.3.5.1. Market Trends and Opportunities
      • 7.6.3.5.2. Growth Prospects
    • 7.6.3.6. Taiwan
      • 7.6.3.6.1. Market Trends and Opportunities
      • 7.6.3.6.2. Growth Prospects
    • 7.6.3.7. Thailand
      • 7.6.3.7.1. Market Trends and Opportunities
      • 7.6.3.7.2. Growth Prospects
    • 7.6.3.8. Others
      • 7.6.3.8.1. Market Trends and Opportunities
      • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisition, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. COSMED srl
• 9.2. Schiller
• 9.3. Sibelmed
• 9.4. Neurosoft, Ivanovo, Russia
• 9.5. PulmOne Advanced Medical Devices
• 9.6. Ganshorn Medizin Electronic GmbH
• 9.7. BTL
• 9.8. MGC Diagnostic Corporation